For US Healthcare Professionals Only

Currently Viewing: 

How to Order Sotalol IV

Sotalol IV (sotalol hydrochloride injection 10 mL vial [15 mg/mL]) is available through your wholesaler.

Product Description

Product NDC Code Description Dimensions Weight
10 mL Vial
69724-112-10
150 mg/10 mL (15 mg/mL)
1.25” W x 1.25” D x 2.65” L
0.29 lbs

Item Numbers for Authorized Wholesalers

Please use the below item numbers to order Sotalol IV (sotalol hydrochloride injection) from your wholesaler.

For additional questions regarding billing and coding, please contact AltaThera’s Market Access team at 1-800-524-1975 or email us at marketaccess@altathera.com

ASD Healthcare Cardinal Health Morris & Dickson McKesson Plasma & Biologics
10251101
5222351
651943
3555158

Information on safe storage and shelf life of Sotalol IV

Sotalol injection is supplied in 10 mL single-dose vials each containing 150 mg of sotalol hydrochloride as a clear solution (15 mg/mL). Store at 20° to 25°C (68° to 77°F); excursions permitted 15° to 30°C (59°to 86°F). Protect from freezing and light. Sotalol IV has a shelf life of 3 years from the date of manufacture. The expiration date of the product is always noted on the label on the vial.

This website is intended for US healthcare professionals only.

By selecting an option below, you certify that you are a licensed US healthcare professional and wish to view information regarding Sotalol IV (sotalol hydrochloride injection). 

I’m using Sotalol IV in…

View adult website

View pediatric website

Highlights of Prescribing Information

Boxed Warning, Indications, and Important Safety Information

WARNING: LIFE THREATENING PROARRHYTHMIA

Sotalol can cause life threatening ventricular tachycardia associated with QT interval prolongation. To minimize the risk of drug induced arrhythmia, initiate or uptitrate intravenous sotalol in a facility that can provide continuous electrocardiographic monitoring and cardiac resuscitation [see Dosage and Administration (2.3) and Warnings and Precautions (5.1)].
Do not initiate intravenous sotalol therapy if the baseline QTc is longer than 450 ms. If the QTc prolongs to 500 ms or greater, reduce the dose or discontinue.